Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05880264
Other study ID # 4-2022-0745
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date June 2023
Est. completion date July 2023

Study information

Verified date May 2023
Source Yonsei University
Contact HYO JIN BYON
Phone 82-10-9134-1566
Email jinoben@naver.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

(1) Maximum respiratory pressure (MRP)1) Maximum inspiratory pressure (maximum intake pressure) and maximum expiratory pressure (MEP) Digital spirometer (Pony FX, COSMED Inc., Italy) are used to measure the micro-paste in a seated position. MIP is based on the pressure maintained for at least 1 second, inhaling or exhaling with maximum effort in the maximum exhalation state (=residual volume) and the maximum exhalation state (=total lung capacity). The maximum positive pressure value of the MEP and the minimum sound pressure value of the MIP are selected among the three or more attempts. 2) Using the MVV (maximum volitional ventilation) Digital spirometer (Pony FX, COSMED Inc., Italy) machine, repeat breathing deeply and quickly for 12 seconds while wearing a nose plug, and multiply it by 5 to obtain the L/min value. (2) Measure the values of the Pneumatic ventilation. · FVC (forced vital capacity): Total expiratory volume of one of the maximum effort gases · FEV1 (forced expiratory volume 1, effort expiratory volume): Ejected expiratory volume of the first second of the maximum effort expiratory volume (FEV1/FVC): FVC ratio, percentage of FVCs, and extraction of the FVC (excessive flow). PEF): Highest speed of effort opportunity


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 200
Est. completion date July 2023
Est. primary completion date July 2023
Accepts healthy volunteers
Gender All
Age group 19 Years to 65 Years
Eligibility Inclusion Criteria: 1. 19 to 65 years old. 2. a patient under general anesthesia 3. Patients in ASA class I to II 4. a patient with no history of thoracic anatomy or surgery 5. Patients with normal chest X-ray findings for preoperative evaluation. Exclusion Criteria: 1. Patients with no natural history of thoracic abnormalities or surgery 2. Patients with asthma, pneumonia, tuberculosis, pneumothorax, chronic obstructive pulmonary disease and epileptic pulmonary disease 3. Patients who have difficulty communicating with the examiner.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Korea, Republic of Severance hospital Seoul

Sponsors (1)

Lead Sponsor Collaborator
Yonsei University

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Measure MIP for healthy Koreans and obtain the reference value A. The subject sits on a chair and covers his nose with a nose plug. B. The patient prepares the test with the Pony Fx MIP/MEP spirometer connected filter in his mouth.
C. After inhaling as much as possible, exhale strongly through the filter with maximum force.
D. At this time, the assistant guides the patient from the side so that the patient can exhale with maximum force.
E. Check the results and select a pressure that is maintained for at least 1 second.
F. The minimum sound pressure value is selected by attempting the A~E process more than three times.
up to 1 year
Primary Measure MEP for healthy Koreans and obtain the reference value. A. The subject sits on a chair and covers his nose with a nose plug. B. The patient prepares the test with the Pony Fx MIP/MEP spirometer connected filter in his mouth.
C. Breathe out as much as you can, and then breathe in strongly through the filter with maximum force.
D. At this time, the assistant guides the patient from the side to breathe in with maximum force.
E. Check the results and select a pressure that is maintained for at least 1 second.
F. The maximum positive pressure value is selected by trying the A~E process more than three times.
up to 1 year
Primary Measure MVV for healthy Koreans and obtain the reference value. A. The subject sits on a chair and covers his nose with a nose plug. B. The patient prepares the test with the Pony Fx MIP/MEP spirometer connected filter in his mouth.
C. Repeat deep and fast breathing for 12 seconds with the start of the test. D. At this time, the assistant looks at the result graph and guides the patient from the side to make the best effort until the end.
E. Multiply the result for 12 seconds by 5 to obtain the L/min value of MVV.
up to 1 year
Secondary Check the predictive equation (forced vital capacity) Measure the above values using a Pulmonary function test Digital spirometer (Pony FX, COSMED Inc., Italy) machine.
FVC (forced vital capacity): Total expiratory volume of one of the maximum effort gases
FEV1 (forced expiratory volume 1, effort expiratory volume): Ejected expiratory volume of the first second of the maximum effort expiratory volume (FEV1/FVC): FVC ratio, percentage of FVCs, and extraction of the FVC (excessive flow).
PEF): Highest speed of effort opportunity
up to 1 year
Secondary Check the predictive equation (forced expiratory volume 1) Measure the above values using a Pulmonary function test Digital spirometer (Pony FX, COSMED Inc., Italy) machine.
FVC (forced vital capacity): Total expiratory volume of one of the maximum effort gases
FEV1 (forced expiratory volume 1, effort expiratory volume): Ejected expiratory volume of the first second of the maximum effort expiratory volume (FEV1/FVC): FVC ratio, percentage of FVCs, and extraction of the FVC (excessive flow).
PEF): Highest speed of effort opportunity
up to 1 year
Secondary Check the predictive equation (FEV1/FVC) Measure the above values using a Pulmonary function test Digital spirometer (Pony FX, COSMED Inc., Italy) machine.
FVC (forced vital capacity): Total expiratory volume of one of the maximum effort gases
FEV1 (forced expiratory volume 1, effort expiratory volume): Ejected expiratory volume of the first second of the maximum effort expiratory volume (FEV1/FVC): FVC ratio, percentage of FVCs, and extraction of the FVC (excessive flow).
PEF): Highest speed of effort opportunity
up to 1 year
Secondary Check the predictive equation (PEF) Measure the above values using a Pulmonary function test Digital spirometer (Pony FX, COSMED Inc., Italy) machine.
FVC (forced vital capacity): Total expiratory volume of one of the maximum effort gases
FEV1 (forced expiratory volume 1, effort expiratory volume): Ejected expiratory volume of the first second of the maximum effort expiratory volume (FEV1/FVC): FVC ratio, percentage of FVCs, and extraction of the FVC (excessive flow).
PEF): Highest speed of effort opportunity
up to 1 year
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04677920 - The Healthy Cookie Energy Study: Understanding How Healthy Cookies Affect Mitochondrial Biology N/A
Active, not recruiting NCT03312920 - Investigating Memory Retrieval Improvement in Healthy Subjects N/A
Completed NCT03309072 - Investigating Accelerated Learning and Memory in Healthy Subjects Using a Face Name Memory Task N/A
Completed NCT03289832 - Effect of Orally Delivered Phytochemicals on Aging and Inflammation in the Skin N/A
Enrolling by invitation NCT06133530 - Human Milk Oligosaccharides (HMOs) and Gut Microbiota, Immune System in Antarctica N/A
Completed NCT05141903 - Dietary Supplement With and Without a Probiotic and/or Antibiotic
Completed NCT01689259 - Comparative Pharmacokinetics and Safety of TNX-102 SL Tablets and Cyclobenzaprine Oral Tablet in Healthy Adults Phase 1
Completed NCT01187875 - Resistant Starch and Satiety Phase 0
Completed NCT03312699 - Effects of Aging on Primary and Secondary Vaccine Responses in a 15-Year Longitudinal Cohort Phase 1
Completed NCT03319134 - Investigating the Neural Correlates in Memory Retrieval After HD-tDCS N/A
Recruiting NCT04104360 - Galacto-oligosaccharides and Intestinal Activity N/A
Completed NCT03228693 - Gene Expression and Biomarker Profiling of Keloid Skin N/A
Completed NCT04146532 - Aspirin Effects on Emotional Reactions Early Phase 1
Completed NCT04206293 - A Study to Evaluate The Impact on Skin Quality Attributes by Juvederm® Volite Injection on Healthy Volunteers N/A
Recruiting NCT06011018 - Comparison of Effects of Mirror Therapy Combined With Neuromuscular Electrical Stimulation or Binaural Beats Stimulation on Cortical Excitability, Heart Rate Variability and Lower Limb Motor Function in Patients With Stroke N/A
Completed NCT05093205 - STUDY TO EVALUATE THE EFFECT OF PF-06882961 ON SINGLE DOSE ATORVASTATIN, MEDAZOLAM AND ORALCONTRACEPTIVE PHARMACOKINETICS IN HEALTHY ADULT PARTICIPANTS Phase 1
Completed NCT04596709 - Investigation of Blood Glucose and Insulin Response After Intake of Vitalose N/A
Completed NCT04272450 - Respiratory Muscle Strength in Different Age Groups
Completed NCT02044679 - Evaluation of Spot Urine as a Biomarker of Fluid Intake in Real Life Conditions N/A
Completed NCT01402973 - Pilot Study of a Dietary Intervention Based Upon Advanced Glycation End Products N/A